Published 1 day ago • loading... • Updated 1 day ago

cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

Yesterday, cbdMD, Inc. reported a 12% revenue increase for the first quarter of fiscal 2026, ending December 31, 2025, in a press release.
After raising approximately $2.25 million in December 2025, cbdMD completed the strategic acquisition of Bluebird Botanicals in mid-January 2026.
Direct-to-Consumer net sales were $3.6 million, representing 72% of total net sales in the quarter, and the transaction includes Bluebird Botanicals' e-commerce assets and GRAS status for full-spectrum CBD.
Ronan Kennedy said `We are encouraged by our return to sequential revenue growth and the continued stabilization of our core business,` after reporting a net loss of approximately $0.32 million while holding $5.4 million in working capital and $3.4 million in cash on February 17, 2026.
Management cautions that forward‑looking statements involve risks and uncertainties as it integrates Bluebird, and filed a definitive proxy statement for the 2025 annual meeting.

Insights by Ground AI

19 Articles

Bennington Banner

+18 Reposted by 18 other sources

Center

cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026

CHARLOTTE, N.C., Feb. 17, 2026 /PRNewswire/ -- cbdMD, Inc. (NYSE American: YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD, Bluebird Botanicals, Paw CBD, along with its…

1 day ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year